SCHEMBL7079847

SCHEMBL7079847

Cc1ccccc1Nc1ccc(C(=NO)c2ccccn2)c(Cl)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 9/20 0.54
MAPK13 O15264 8/20 0.54
MAPK12 P53778 8/20 0.54
MAPK11 Q15759 8/20 0.54
GRM4 Q14833 6/20 0.48
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
PTK6 Q13882 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.39
MAPT P10636 1/20 0.39
CYP2C9 P11712 1/20 0.39
HPGD P15428 1/20 0.39
NFKB1 P19838 1/20 0.39
CYP2C19 P33261 1/20 0.39
HTT P42858 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7079846 1.00 MAPK14 (0.54) MAPK14MAPK13MAPK12MAPK11GRM4
SCHEMBL7079512 0.85 MAPK14 (0.53) MAPK14MAPK13MAPK12MAPK11GRM4
SCHEMBL7079509 0.85 MAPK14 (0.53) MAPK14MAPK13MAPK12MAPK11GRM4
SCHEMBL7082605 0.84 MAPK14 (0.70) MAPK14MAPK13MAPK12MAPK11GRM4
SCHEMBL7076132 0.84 MAPK14 (0.56) MAPK14MAPK13MAPK12MAPK11GRM4
SCHEMBL7081913 0.83 MAPK14 (0.53) MAPK14MAPK13MAPK12MAPK11GRM4
SCHEMBL7081916 0.83 MAPK14 (0.53) MAPK14MAPK13MAPK12MAPK11GRM4
SCHEMBL5173645 0.83 MAPK14 (0.68) MAPK14MAPK13MAPK12MAPK11GRM4
SCHEMBL7081239 0.83 MAPK14 (0.55) MAPK14MAPK13MAPK12MAPK11NPC1
SCHEMBL7081236 0.83 MAPK14 (0.55) MAPK14MAPK13MAPK12MAPK11NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030073832-A1 Novel aminophenyl ketone derivatives LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-17 US claimed
US-20030073832-A1 Novel aminophenyl ketone derivatives LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073832-A1 Novel aminophenyl ketone derivatives MAPKAPK2, MAP3K2, MAP3K1 MAPK14 28/4885MAPK13 33/4885MAPK12 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.